LEP and Insulin resistance: A lower expression of anti-inflammatory adipokines (eg, adiponectin) and higher expression of proinflammatory adipokines (eg, leptin, resistin, visfatin) contributes to the systemic subclinical inflammation and progressive insulin resistance with increased risk of type 2 diabetes (82).